Systemic hypoxia or Foxp3-directed Phd2 silencing cause immune activation and augment the protective immune response to BCG

Information from the abstract

Abstract Hypoxia has widespread physiological effects, many of which are mediated through decreased activity of prolyl hydroxylase domain-2 (Phd2) which is the major oxygen-sensing hydroxylase controlling the hypoxia-inducible factor (HIF) transcriptional pathways. Here we demonstrate that in mice Phd2 silencing restricted to regulatory T cells or environmental hypoxic exposure can lead to the development of autoimmunity as evidenced by peripheral lymphadenopathy with multi-lineage leukocyte expansion and the development of anti-nuclear antibodies. Furthermore, the immune activation triggered by these manipulations can be harnessed to enhance the response to Bacillus Calmette-Guérin (BCG) immunisation, as measured by an ex vivo mycobacterial growth inhibition assay. The effects of Phd2 silencing and hypoxia are both mitigated in Hif-2alpha deficient mice. However, loss of Hif-1alpha (alone or in combination with Hif-2alpha) provokes an accentuated phenotype in response to hypoxia.

Why this record is monitored

This record has an Impact Signal of 71/100 based on recency, source, collaboration, and bibliographic signals. It prioritizes monitoring and is not a judgment of research quality.

Related topics: Cancer, Hypoxia, and Metabolism · High Altitude and Hypoxia · interferon and immune responses